Last reviewed · How we verify
CTX0E03 neural stem cells
At a glance
| Generic name | CTX0E03 neural stem cells |
|---|---|
| Sponsor | ReNeuron Limited |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Pilot Investigation of Stem Cells in Stroke (PHASE1)
- Investigation of Neural Stem Cells in Ischemic Stroke (PHASE2)
- Pilot Investigation of Stem Cells in Stroke Phase II Efficacy (PHASE2)
- Safety Trial Of CTX Cells In Patients With Lower Limb Ischaemia (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CTX0E03 neural stem cells CI brief — competitive landscape report
- CTX0E03 neural stem cells updates RSS · CI watch RSS
- ReNeuron Limited portfolio CI